Identification of microRNAome in rat bladder reveals miR-1949 as a potential inducer of bladder cancer following spinal cord injury

Wang,Tianyi; Liu,Yong; Yuan,Wenqi; Zhang,Liang; Zhang,Yanjun; Wang,Zhijie; Zhou,Xianhu; Zhou,Hengxing; Chu,Tianci; Hao,Yan; Liu,Bin; Zhao,Xuechao; Lu,Lu; Feng,Shiqing; Kong,Xiaohong

doi:10.3892/mmr.2015.3769

Identification of microRNAome in rat bladder reveals miR-1949 as a potential inducer of bladder cancer following spinal cord injury

Authors:
- Tianyi Wang
- Yong Liu
- Wenqi Yuan
- Liang Zhang
- Yanjun Zhang
- Zhijie Wang
- Xianhu Zhou
- Hengxing Zhou
- Tianci Chu
- Yan Hao
- Bin Liu
- Xuechao Zhao
- Lu Lu
- Shiqing Feng
- Xiaohong Kong
View Affiliations

Affiliations: Department of Orthopedics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China, Department of Orthopedics, The Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China, Department of Paediatric Internal Medicine, Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, P.R. China, 221 Laboratory, School of Medicine, Nankai University, Tianjin 300071, P.R. China
Published online on: May 12, 2015 https://doi.org/10.3892/mmr.2015.3769
Pages: 2849-2857

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The costs of spinal cord injury and its complications are high in personal, social and financial terms. Complications include bladder cancer, for which the risk is 16‑28 times higher than that of the general population, There is currently little consensus regarding the cause of this discrepancy. As microRNAs are stable biomarkers and potential therapeutic targets of cancer, the present study aimed to explore the underlying mechanisms of this phenomenon by examining changes in the microRNAome. Rats were used to produce models of spinal cord injury. Microarrays and bioinformatics were used to investigate the cancer‑associated microRNAs that are upregulated in rat bladders following spinal cord injury. In order to validate the results, quantitative reverse transcription‑polymerase chain reaction (qRT‑PCR), western blotting and immunohistochemistry were performed. The expression of miR‑1949 was found to be deregulated and abundant in the rat bladder following spinal cord injury. Bioinformatics demonstrated that retinoblastoma 1, which is involved in tumorigenesis, is a target gene of miR‑1949. qRT‑PCR, western blotting and immunohistochemistry confirmed the results of the microarray analysis. In addition, it was shown that miR‑1949 expression was not influenced by aging. Furthermore, the expression of miR‑1949 was stable until the third month following spinal cord injury, after which it significantly increased. If this increase was prolonged, the expression of retinoblastoma 1 may decline to a carcinogenic level. The present study suggests a role for miR‑1949 in the translational regulation of retinoblastoma 1 and in subsequent bladder tumorigenesis following spinal cord injury.

View Figures

View References

1	Williams AE: Functional aspects of animal microRNAs. Cell Mol Life Sci. 65:545–562. 2008. View Article : Google Scholar
2	Nagalla S, Shaw C, Kong X, et al: Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood. 117:5189–5197. 2011. View Article : Google Scholar : PubMed/NCBI
3	Hou J, Lin L, Zhou W, et al: Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell. 19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
4	Munding JB, Adai AT, Maghnouj A, et al: Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer. 131:E86–E95. 2012. View Article : Google Scholar
5	Hua R, Shi J, Wang X, et al: Analysis of the causes and types of traumatic spinal cord injury based on 561 cases in China from 2001 to 2010. Spinal cord. 51:218–221. 2013. View Article : Google Scholar
6	Bejany DE, Lockhart JL and Rhamy RK: Malignant vesical tumors following spinal cord injury. J Urol. 138:1390–1392. 1987.PubMed/NCBI
7	Groah SL, Weitzenkamp DA, Lammertse DP, Whiteneck GG, Lezotte DC and Hamman RF: Excess risk of bladder cancer in spinal cord injury: Evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil. 83:346–351. 2002. View Article : Google Scholar : PubMed/NCBI
8	Subramonian K, Cartwright RA, Harnden P and Harrison SC: Bladder cancer in patients with spinal cord injuries. BJU Int. 93:739–743. 2004. View Article : Google Scholar : PubMed/NCBI
9	Kalisvaart JF, Katsumi HK, Ronningen LD and Hovey RM: Bladder cancer in spinal cord injury patients. Spinal Cord. 48:257–261. 2010. View Article : Google Scholar
10	Kaufman JM, Fam B, Jacobs SC, et al: Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol. 118:967–971. 1977.PubMed/NCBI
11	Geisse LJ and Tweeddale DN: Pre-clinical cytological diagnosis of bladder cancer. J Urol. 120:51–56. 1978.PubMed/NCBI
12	Pannek J: Transitional cell carcinoma in patients with spinal cord injury: A high risk malignancy? Urology. 59:240–244. 2002. View Article : Google Scholar : PubMed/NCBI
13	West DA, Cummings JM, Longo WE, Virgo KS, Johnson FE and Parra RO: Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology. 53:292–297. 1999. View Article : Google Scholar : PubMed/NCBI
14	Lau P, Verrier JD, Nielsen JA, Johnson KR, Notterpek L and Hudson LD: Identification of dynamically regulated microRNA and mRNA networks in developing oligodendrocytes. J Neurosci. 28:11720–11730. 2008. View Article : Google Scholar : PubMed/NCBI
15	Sparkes RS, Sparkes MC, Wilson MG, et al: Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. Science. 208:1042–1044. 1980. View Article : Google Scholar : PubMed/NCBI
16	Miyamoto H, Shuin T, Torigoe S, Iwasaki Y and Kubota Y: Retinoblastoma gene mutations in primary human bladder cancer. Br J Cancer. 71:831–835. 1995. View Article : Google Scholar : PubMed/NCBI
17	Mitra AP, Hansel DE and Cote RJ: Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Semin Oncol. 39:524–533. 2012. View Article : Google Scholar : PubMed/NCBI
18	Workman P, Aboagye EO, Balkwill F, et al: Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 102:1555–1577. 2010. View Article : Google Scholar : PubMed/NCBI
19	Ban DX, Kong XH, Feng SQ, Ning GZ, Chen JT and Guo SF: Intraspinal cord graft of autologous activated Schwann cells efficiently promotes axonal regeneration and functional recovery after rat’s spinal cord injury. Brain Res. 1256:149–161. 2009. View Article : Google Scholar
20	Zhou HX, Li XY, Li FY, et al: Targeting RPTPsigma with lentiviral shRNA promotes neurites outgrowth of cortical neurons and improves functional recovery in a rat spinal cord contusion model. Brain research. 1586:46–63. 2014. View Article : Google Scholar
21	Liu Y, Wang CY, Kong XH, et al: Novel multifunctional polyethylene glycoltransactivating-transduction protein-modified liposomes cross the blood-spinal cord barrier after spinal cord injury. J Drug Target. 18:420–429. 2010. View Article : Google Scholar
22	Andreollo NA, Santos EF, Araújo MR and Lopes LR: Rat’s age versus human’s age: What is the relationship? Arq Bras Cir Dig. 25:49–51. 2012.In English, Portuguese. View Article : Google Scholar : PubMed/NCBI
23	Quinn R: Comparing rat’s to human’s age: How old is my rat in people years? Nutrition. 21:775–777. 2005. View Article : Google Scholar : PubMed/NCBI
24	Lee H, Jun SY, Lee YS, Lee HJ, Lee WS and Park CS: Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder. Virchows Arch. 464:213–220. 2014. View Article : Google Scholar
25	Ratert N, Meyer HA, Jung M, et al: miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome. J Mol Diagn. 15:695–705. 2013. View Article : Google Scholar : PubMed/NCBI
26	Tran MN, Choi W, Wszolek MF, et al: The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: Role of MIR-205. J Biol Chem. 288:3275–3288. 2013. View Article : Google Scholar :
27	Dip N, Reis ST, Timoszczuk LS, et al: Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile. J Urol. 188:1951–1956. 2012. View Article : Google Scholar : PubMed/NCBI
28	Wang G, Chan ES, Kwan BC, et al: Expression of microRNAs in the urine of patients with bladder cancer. Clin Genitourin Cancer. 10:106–113. 2012. View Article : Google Scholar : PubMed/NCBI
29	Wiklund ED, Bramsen JB, Hulf T, et al: Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer. 128:1327–1334. 2011. View Article : Google Scholar
30	Neely LA, Rieger-Christ KM, Neto BS, et al: A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol. 28:39–48. 2010. View Article : Google Scholar
31	Gottardo F, Liu CG, Ferracin M, et al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
32	Friedman JM, Liang G, Liu CC, et al: The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res. 69:2623–2629. 2009. View Article : Google Scholar : PubMed/NCBI
33	Han Y, Chen J, Zhao X, et al: MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One. 6:e182862011. View Article : Google Scholar : PubMed/NCBI
34	Yamada Y, Enokida H, Kojima S, et al: MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: Correlation with stage and grade, and comparison with urinary cytology. Cancer Sci. 102:522–529. 2011. View Article : Google Scholar
35	Pignot G, Cizeron-Clairac G, Vacher S, et al: microRNA expression profile in a large series of bladder tumors: Identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer. 132:2479–2491. 2013. View Article : Google Scholar
36	Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M and Enokida H: Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol. 10:396–404. 2013. View Article : Google Scholar : PubMed/NCBI
37	Zhang QH, Sun HM, Zheng RZ, et al: Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Gene. 527:26–32. 2013. View Article : Google Scholar : PubMed/NCBI
38	Xu Q, Seeger FH, Castillo J, et al: Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease. J Am Coll Cardiol. 59:2107–2117. 2012. View Article : Google Scholar : PubMed/NCBI
39	Ito T, Yagi S and Yamakuchi M: MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun. 398:735–740. 2010. View Article : Google Scholar : PubMed/NCBI
40	Nishino J, Kim I, Chada K and Morrison SJ: Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell. 135:227–239. 2008. View Article : Google Scholar : PubMed/NCBI
41	Li S, Zhu J, Zhang W, et al: Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation. 124:175–184. 2011. View Article : Google Scholar : PubMed/NCBI
42	Liu CG, Calin GA, Volinia S and Croce CM: MicroRNA expression profiling using microarrays. Nat Protoc. 3:563–578. 2008. View Article : Google Scholar : PubMed/NCBI
43	Brown BD, Gentner B, Cantore A, et al: Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol. 25:1457–1467. 2007. View Article : Google Scholar : PubMed/NCBI
44	Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH and Filipowicz W: Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med. 15:31–33. 2009. View Article : Google Scholar : PubMed/NCBI
45	Esuvaranathan K, Chiong E, Thamboo TP, et al: Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha. Cancer. 109:1097–1105. 2007. View Article : Google Scholar : PubMed/NCBI
46	Lu X, Wu L, Liu Z, Xie L and Wang S: Peripheral blood mono-nuclear cells inhibit proliferation and promote apoptosis of HeLa cells following stimulation with Bacillus Calmette-Guerin. Exp Ther Med. 5:561–566. 2013.PubMed/NCBI
47	Kawaichi S: Cancer of bladder os spinal cord injury patients. Proceed Ninth Ann Clin Cord Injury Conf; pp. 104–105. 1961
48	Silverman DT, Hartge P, Morrison AS and Devesa SS: Epidemiology of bladder cancer. Hematol Oncol Clin North Am. 6:1–30. 1992.PubMed/NCBI
49	Burch JD, Rohan TE, Howe GR, et al: Risk of bladder cancer by source and type of tobacco exposure: A case-control study. Int J Cancer. 44:622–628. 1989. View Article : Google Scholar : PubMed/NCBI